
Gold nanoparticle aggregates (red) are observed inside triple negative breast cancer cells after an enzyme-activated assembly and internalization process.
(photo credit: Richard Huang and Ye He)
The breakthrough advance could lead to a novel, drug-free therapeutic that can slow, possibly stop, the growth of cancer cells
A multi-institutional research team has designed nanoparticles that can communicate with and slow the development of cancer cells. The work — detailed in a newly published paper in Advanced Materials — has uncovered a novel framework for the potential development of drug-free cancer therapies.
Led by scientists at the Advanced Science Research Center at the Graduate Center, CUNY (CUNY ASRC), the research team was able to design nanoparticles that are activated to self-assemble when they encounter cancer cells and send messages to instruct the cells to slow their growth. Because the nanoparticles communicate only with the cancer cells, the surrounding healthy cells aren’t impacted.
“Cancer cells take up materials from their environment, and they also secrete factors that help them degrade surrounding tissue in order to spread and metastasize,” said Richard Huang, lead author of the paper, a Ph.D. student at the Graduate Center, CUNY (GC CUNY), and a researcher with the CUNY ASRC Nanoscience Initiative and the Center for Discovery and Innovation at CUNY’s City College of New York (CCNY). “We made particles that respond to both of these characteristics by aggregating into clusters that are actively taken up by cancer cells. Once inside, they appear to be able to reduce the cancer cells’ metabolic activity and consequently reduce their growth.
One reason the progression of cancer is difficult to control is that the cells secrete an abnormally large amount of the matrix metalloproteinase-9 (MMP-9) enzyme, which breaks down the collagen that holds together healthy tissue. The research team was able to use this feature against the cancer cells. This is achieved by designing nanoparticles that when triggered by MMP-9, begin assembling to large aggregates in the cells’ vicinity. The cells engulf these aggregates, and their size causes physical distress to the cancer cells and reduces their ability to proliferate and survive.
One highlight of the study is that the researchers were able to use confocal reflection microscopy to visualize the nanoparticle aggregates inside the cancer cells in real-time. “This label-free, live imaging technique allowed us to have a closer look at when and where the aggregates were formed, and how the cancer cells respond to the particles at the sub-cellular level,” said Ye He, director of the Live Imaging and Bioenergetics Facility in the CUNY ASRC Neuroscience Initiative.
“Through this research, we wanted to determine whether it’s possible to make use of relatively simple peptide design to create nanoparticles that could produce robust self-assembly in biological media and have an impact on cancer cells,” said Rein Ulijn, director of the CUNY ASRC Nanoscience Initiative and the study’s principal investigator. “While this is early-stage research, the findings provide exciting possibilities for a drug-free therapeutic treatment that could be extremely useful for cancer patients who have developed drug resistance and for extending the lives of people with metastatic cancer.”
Further studies are needed to fully access the therapeutic potential of the team’s discovery.
Original Article: Scientists Design Nanoparticles That Communicate With Cancer Cells
More from: City University of New York | University of Strathclyde | Weizmann Institute of Science
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Self-assembling nanoparticles
- ‘DNA origami’ may bring researchers one step closer to a cancer vaccine
Professor Leo Chou (BME) has developed a new way to visualize 3D nanostructures made of human DNA under the microscope ...
- Self-assembly in Supramolecular and Organic Chemistry
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the ...
- Self-assembly articles from across Nature Portfolio
Self-assembly is the process by which an organized ... small molecules and nanoparticles shows that high-performance barrier materials can be manufactured by means of entropy-driven assembly.
- Scaling up nano for sustainable manufacturing
A research team has developed a high-performance coating material that self-assembles from 2D nanosheets, and which could significantly extend the shelf life of electronics, energy storage devices, ...
- Scaling up nano for sustainable manufacturing with self-assembling nanosheets
A new self-assembling nanosheet could radically accelerate the development of functional and sustainable nanomaterials for electronics, energy storage, health and safety, and more.
Go deeper with Google Headlines on:
Self-assembling nanoparticles
[google_news title=”” keyword=”self-assembling nanoparticles” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Drug-free cancer treatment
- DelveInsight Business Research, LLP: Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period (2019-2032) | DelveInsight
Apart from the already existing players such as Pfizer, Sanofi, Taiho Pharma, Ono Pharma, along with others, there are several emerging key players, that are expected to change the dynamics of the ...
- J&J (JNJ) Seeks Expanded Use of Lung Cancer Drug Rybrevant
J&J's (JNJ) sBLA seeks label expansion for Rybrevant plus chemotherapy to treat patients with EGFR-mutated NSCLC whose disease progressed on or after treatment with AstraZeneca's Tagrisso (osimertinib ...
- Latest Drug Discovery Sets Way For Pancreatic Cancer Clinical Trial; Here's How
Laboratory findings have set the stage for a clinical trial investigating a drug for pancreatic cancer that has spread to the liver. Pancreatic cancer is tricky to manage because it spreads quickly ...
- New breast cancer drug beats Tamoxifen
Women taking a new breast cancer drug are living longer than those taking Tamoxifen - the current 'gold standard' treatment ... taking Arimidex remain disease-free for longer than those on ...
- 2seventy slides on latest roadblock for cancer drug
The cancer-focused spinout of bluebird bio Inc. has hit another roadblock for its cancer drug, Abecma — the company's only approved product.
Go deeper with Google Headlines on:
Drug-free cancer treatment
[google_news title=”” keyword=”drug-free cancer treatment” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]